What does PHARMACIE JOLIBOIS-DELAIVE do?

PHARMACIE JOLIBOIS-DELAIVE is a pharmacy in Nandrin. Private Limited, started on 4 July 2006, 1 establishment.

What is the address of PHARMACIE JOLIBOIS-DELAIVE?

The registered office of PHARMACIE JOLIBOIS-DELAIVE is located at Bois de la Croix Claire 2, 4550 Nandrin.

Is PHARMACIE JOLIBOIS-DELAIVE still active?

Yes. According to the CBE (17 September 2026) PHARMACIE JOLIBOIS-DELAIVE is active, legal situation “Normale toestand”, started on 4 July 2006.

Is PHARMACIE JOLIBOIS-DELAIVE registered on Peppol?

Yes, PHARMACIE JOLIBOIS-DELAIVE is registered on the Peppol network with ID 0208:0882273594.

What is the enterprise number of PHARMACIE JOLIBOIS-DELAIVE?

The enterprise number of PHARMACIE JOLIBOIS-DELAIVE is BE0882273594.

When was PHARMACIE JOLIBOIS-DELAIVE founded?

PHARMACIE JOLIBOIS-DELAIVE was founded on 4 July 2006.

Who are the directors of PHARMACIE JOLIBOIS-DELAIVE?

According to the 2025 annual accounts, the directors of PHARMACIE JOLIBOIS-DELAIVE are: Philippe JOLIBOIS.

Is PHARMACIE JOLIBOIS-DELAIVE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 4 July 2006; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did PHARMACIE JOLIBOIS-DELAIVE make in 2025?

PHARMACIE JOLIBOIS-DELAIVE posted a profit after taxes of € 110,076 in financial year 2025.

What is the revenue of PHARMACIE JOLIBOIS-DELAIVE?

As a small company, PHARMACIE JOLIBOIS-DELAIVE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 300,892.

How much does an employee at PHARMACIE JOLIBOIS-DELAIVE earn?

The average wage cost per full-time employee at PHARMACIE JOLIBOIS-DELAIVE was € 80,300 in 2025: staff costs of € 112,360 for 1.4 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does PHARMACIE JOLIBOIS-DELAIVE have?

According to the 2025 annual accounts, PHARMACIE JOLIBOIS-DELAIVE has 1.4 full-time equivalents (FTE).

PHARMACIE JOLIBOIS-DELAIVE (Private Limited) - Nandrin

Dossier PHARMACIE JOLIBOIS-DELAIVE, printed on 17 September 2026 from databakkes.be/en/0882273594/pharmacie-jolibois-delaive. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

PHARMACIE JOLIBOIS-DELAIVE from Nandrin, company number BE0882273594, closed financial year 2025 with a result of € 110,076 after tax. For that financial year PHARMACIE JOLIBOIS-DELAIVE recorded a gross margin of € 300,892 and equity of € 491,565. Compared with financial year 2024, the result moved from € 95,733 to € 110,076. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 20, 2026.

What it is worth Healthy

€ 491,565

▼ 12% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 110,076

▲ 15% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 307,720

▲ 12% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 175,666 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents

1.4

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 112,360

▲ 3% vs 2024

€ 80,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 47,047

▼ 2% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 5,908

▼ 69% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 41,892

▲ 5% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 57,373

▲ 59% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 275,050 Gross margin 2022: € 275,050 First fiscal year in the series	€ 275,582 Gross margin 2023: € 275,582 Unchanged (€ 275,050) Favourable step	€ 282,469 Gross margin 2024: € 282,469 ▲ 2% vs 2023 (€ 275,582) Favourable step	€ 300,892 Gross margin 2025: € 300,892 ▲ 7% vs 2024 (€ 282,469) Favourable step	▲ 7%
Profit after taxes	€ 103,791 Profit after taxes 2022: € 103,791 First fiscal year in the series	€ 94,252 Profit after taxes 2023: € 94,252 ▼ 9% vs 2022 (€ 103,791) Unfavourable step	€ 95,733 Profit after taxes 2024: € 95,733 ▲ 2% vs 2023 (€ 94,252) Favourable step	€ 110,076 Profit after taxes 2025: € 110,076 ▲ 15% vs 2024 (€ 95,733) Favourable step	▲ 15%
Equity	€ 399,502 Equity 2022: € 399,502 First fiscal year in the series	€ 489,089 Equity 2023: € 489,089 ▲ 22% vs 2022 (€ 399,502) Favourable step	€ 557,155 Equity 2024: € 557,155 ▲ 14% vs 2023 (€ 489,089) Favourable step	€ 491,565 Equity 2025: € 491,565 ▼ 12% vs 2024 (€ 557,155) Unfavourable step	▼ 12%
Total debts	€ 190,953 Total debts 2022: € 190,953 First fiscal year in the series	€ 148,131 Total debts 2023: € 148,131 ▼ 22% vs 2022 (€ 190,953) Favourable step	€ 97,402 Total debts 2024: € 97,402 ▼ 34% vs 2023 (€ 148,131) Favourable step	€ 197,641 Total debts 2025: € 197,641 ▲ 103% vs 2024 (€ 97,402) Unfavourable step	▲ 103%
Cash	€ 195,513 Cash 2022: € 195,513 First fiscal year in the series	€ 238,101 Cash 2023: € 238,101 ▲ 22% vs 2022 (€ 195,513) Favourable step	€ 275,542 Cash 2024: € 275,542 ▲ 16% vs 2023 (€ 238,101) Favourable step	€ 307,720 Cash 2025: € 307,720 ▲ 12% vs 2024 (€ 275,542) Favourable step	▲ 12%
Land & buildings	€ 34,361 Land & buildings 2022: € 34,361 First fiscal year in the series	€ 27,049 Land & buildings 2023: € 27,049 ▼ 21% vs 2022 (€ 34,361) Unchanged	€ 19,738 Land & buildings 2024: € 19,738 ▼ 27% vs 2023 (€ 27,049) Unchanged	€ 12,427 Land & buildings 2025: € 12,427 ▼ 37% vs 2024 (€ 19,738) Unchanged	▼ 37%
Retained profit	€ 380,902 Retained profit 2022: € 380,902 First fiscal year in the series	€ 470,489 Retained profit 2023: € 470,489 ▲ 24% vs 2022 (€ 380,902) Favourable step	€ 538,555 Retained profit 2024: € 538,555 ▲ 14% vs 2023 (€ 470,489) Favourable step	€ 472,965 Retained profit 2025: € 472,965 ▼ 12% vs 2024 (€ 538,555) Unfavourable step	▼ 12%
Dividend	€ 27,000 Dividend 2022: € 27,000 First fiscal year in the series	€ 4,666 Dividend 2023: € 4,666 ▼ 83% vs 2022 (€ 27,000) Unchanged	€ 27,666 Dividend 2024: € 27,666 ▲ € 23,000 vs 2023 (€ 4,666) Unchanged	€ 175,666 Dividend 2025: € 175,666 ▲ € 148,000 vs 2024 (€ 27,666) Unchanged	▲ € 148,000
Bank debt	€ 62,514 Bank debt 2022: € 62,514 First fiscal year in the series	€ 40,753 Bank debt 2023: € 40,753 ▼ 35% vs 2022 (€ 62,514) Favourable step	€ 18,763 Bank debt 2024: € 18,763 ▼ 54% vs 2023 (€ 40,753) Favourable step	€ 5,908 Bank debt 2025: € 5,908 ▼ 69% vs 2024 (€ 18,763) Favourable step	▼ 69%
Balance sheet total	€ 590,456 Balance sheet total 2022: € 590,456 First fiscal year in the series	€ 637,220 Balance sheet total 2023: € 637,220 ▲ 8% vs 2022 (€ 590,456) Unchanged	€ 654,558 Balance sheet total 2024: € 654,558 ▲ 3% vs 2023 (€ 637,220) Unchanged	€ 689,206 Balance sheet total 2025: € 689,206 ▲ 5% vs 2024 (€ 654,558) Unchanged	▲ 5%
Employees (FTE)	1.4 Employees (FTE) 2022: 1.4 First fiscal year in the series	1.4 Employees (FTE) 2023: 1.4 Unchanged (1.4) Unchanged	1.4 Employees (FTE) 2024: 1.4 Unchanged (1.4) Unchanged	1.4 Employees (FTE) 2025: 1.4 Unchanged (1.4) Unchanged

Key figures of PHARMACIE JOLIBOIS-DELAIVE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACIE JOLIBOIS-DELAIVE?

What happened at PHARMACIE JOLIBOIS-DELAIVE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 20, 2026 New annual accounts for financial year 2025: profit of € 110,076 (▲ 15% vs 2024). filed late Source: NBB ↗
Aug 1, 2006 New establishment in Seraing. KBO
Jul 4, 2006 Start of the company according to the CBE. KBO

In short

From € 103,791 profit in 2022 to € 110,076 profit in 2025.

Paid € 169,013 in corporate taxes since 2022.

Best year ever: 2025, with € 110,076 profit.

On average € 214,900 of value added per employee in 2025.

Original PDFs at the National Bank ↗

A new publication or filing at PHARMACIE JOLIBOIS-DELAIVE? We notify you, reason included.

Follow PHARMACIE JOLIBOIS-DELAIVE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Philippe JOLIBOIS

PHARMACIE JOLIBOIS-DELAIVE

Behind PHARMACIE JOLIBOIS-DELAIVE is Philippe JOLIBOIS.

See the full network in the app

Directors

According to the 2025 annual accounts

Philippe JOLIBOIS

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Bois de la Croix Claire 2

4550 Nandrin

2.155.176.583

Rue de Plainevaux 28

4100 Seraing

Active since 1 August 2006

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0882.273.594

VAT number

BE 0882.273.594

Registered office

Bois de la Croix Claire 2, 4550 Nandrin

Names & denominations

PHARMACIE JOLIBOIS-DELAIVE

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

4 July 2006

Peppol

Active · Active since 6 Nov 2025

Contact

pharmaciejolibois.be [email protected] 043362438

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMACIE JOLIBOIS-DELAIVE

Financials

What happened to PHARMACIE JOLIBOIS-DELAIVE?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions